SPONSORED CONTENT
The revised 340B Rebate Model is moving forward, and with implementation now scheduled for January 1, 2027, covered entities have entered a new phase of preparation. While many questions remain, one thing is clear: organizations should begin evaluating the
…SPONSORED CONTENT
340B program compliance seems to become more complicated each year, with new reporting obligations, scrutiny and expectations. Even seasoned 340B program health center staff can feel overwhelmed by the volume and pace of developments in the
…SPONSORED CONTENT
For many safety-net healthcare organizations, the 340B program represents more than a financial opportunity. When implemented thoughtfully, it can become a
…
Q: What is the primary problem 340B Referral Capture solves?
Covered entities (CEs) routinely miss a large share of the 340B savings they’re entitled to because…
Read More »SPONSORED CONTENT
Hospitals that serve a high volume of low-income and uninsured patients rely on Disproportionate Share Hospital (DSH) funding to maintain financial
…SPONSORED CONTENT
The 340B Coalition Summer Conference 2026 arrived at a pivotal moment for the program. Since the winter conference, manufacturer restrictions have continued to evolve, federal officials have taken additional steps toward a potential rebate model, and recent
…
Q: Where did you grow up?
I grew up in Lansing, Michigan.
Q: Tell us about your educational background and training.
I obtained my Bachelor of Business Administration from Northwood Institute in Midland, MI and my Juris Doctorate from Cooley Law School in Michigan.
Q: What are your favorites?
Food: steak, grape leaves
…SPONSORED CONTENT
As 2026 reaches its midpoint, 340B covered entities (CEs) are operating in an environment defined less by one sweeping policy change and more by the accumulation of operational pressure across the
…SPONSORED CONTENT
The implementation of Medicare’s Maximum Fair Price (MFP) program under the Inflation Reduction Act has introduced one of the most operationally significant changes to pharmaceutical reimbursement in decades, one that has important ramifications for 340B
…
Q: Where did you grow up?
Fayetteville, Arkansas
Q: Tell us about your educational background and training.
I started my career in pharmacy working with Oklahoma Medicaid as a pharmacy analyst. My career grew from there when I transitioned to working as a consultant for multiple Medicaid pharmacy programs and then transitioned into 340B
…
